Second, because there was no significant difference in the expansion of the RPE atrophy between the continued and suspended anti-VEGF agent treatment groups, it is not reasonable to suspend treatment with an anti-VEGF agent to prevent the expansion of RPE atrophy. Here, VEGFA is linked to Atrophy.